CD4 and neoplasm: DCP-IL-12/FLT3L dramatically increased tumor infiltration by hematopoietic cells, CD8+ and CD4+ T cells compared to DCPs expressing either cytokine alone (Fig. 2d and Extended Data Fig. 5c).